Ann: New Data at SITC Meeting. Further Studies Announced, page-5

  1. 1,626 Posts.
    lightbulb Created with Sketch. 109
    Yeah but at at least they are chipping in the Keytruda, which isn't cheap. If thru ate looking to have say 300 patients and its costs $130k(?)per annum to be on the stuff....
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.